FDA Approved: ZOLEDRONIC ACID — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a supplemental application for zoledronic acid submitted by BluePoint Laboratories (ANDA205279).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Hypercalcemia of Malignancy
• Multiple Myeloma
• Osteoporosis

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

SUPPL AP for ZOLEDRONIC ACID (ZOLEDRONIC ACID)